BACKGROUND AND PURPOSE: Along with cortical abnormalities, white matter microstructural changes such as axonal loss and myelin breakdown are implicated in the pathogenesis of Alzheimer disease. Recently, a white matter model was introduced that relates non-Gaussian diffusional kurtosis imaging metrics to characteristics of white matter tract integrity, including the axonal water fraction, the intra-axonal diffusivity, and the extra-axonal axial and radial diffusivities. MATERIALS AND METHODS: This study reports these white matter tract integrity metrics in subjects with amnestic mild cognitive impairment (n = 12), Alzheimer disease (n = 14), and age-matched healthy controls (n = 15) in an effort to investigate their sensitivity, diagnostic accuracy, and associations with white matter changes through the course of Alzheimer disease. RESULTS: With tract-based spatial statistics and region-of-interest analyses, increased diffusivity in the extra-axonal space (extra-axonal axial and radial diffusivities) in several white matter tracts sensitively and accurately discriminated healthy controls from those with amnestic mild cognitive impairment (area under the receiver operating characteristic curve = 0.82-0.95), while widespread decreased axonal water fraction discriminated amnestic mild cognitive impairment from Alzheimer disease (area under the receiver operating characteristic curve = 0.84). Additionally, these white matter tract integrity metrics in the body of the corpus callosum were strongly correlated with processing speed in amnestic mild cognitive impairment (r = |0.80-0.82|, P < .001). CONCLUSIONS: These findings have implications for the course and spatial progression of white matter degeneration in Alzheimer disease, suggest the mechanisms by which these changes occur, and demonstrate the viability of these white matter tract integrity metrics as potential neuroimaging biomarkers of the earliest stages of Alzheimer disease and disease progression.
BACKGROUND AND PURPOSE: Along with cortical abnormalities, white matter microstructural changes such as axonal loss and myelin breakdown are implicated in the pathogenesis of Alzheimer disease. Recently, a white matter model was introduced that relates non-Gaussian diffusional kurtosis imaging metrics to characteristics of white matter tract integrity, including the axonal water fraction, the intra-axonal diffusivity, and the extra-axonal axial and radial diffusivities. MATERIALS AND METHODS: This study reports these white matter tract integrity metrics in subjects with amnestic mild cognitive impairment (n = 12), Alzheimer disease (n = 14), and age-matched healthy controls (n = 15) in an effort to investigate their sensitivity, diagnostic accuracy, and associations with white matter changes through the course of Alzheimer disease. RESULTS: With tract-based spatial statistics and region-of-interest analyses, increased diffusivity in the extra-axonal space (extra-axonal axial and radial diffusivities) in several white matter tracts sensitively and accurately discriminated healthy controls from those with amnestic mild cognitive impairment (area under the receiver operating characteristic curve = 0.82-0.95), while widespread decreased axonal water fraction discriminated amnestic mild cognitive impairment from Alzheimer disease (area under the receiver operating characteristic curve = 0.84). Additionally, these white matter tract integrity metrics in the body of the corpus callosum were strongly correlated with processing speed in amnestic mild cognitive impairment (r = |0.80-0.82|, P < .001). CONCLUSIONS: These findings have implications for the course and spatial progression of white matter degeneration in Alzheimer disease, suggest the mechanisms by which these changes occur, and demonstrate the viability of these white matter tract integrity metrics as potential neuroimaging biomarkers of the earliest stages of Alzheimer disease and disease progression.
Authors: Claire E Sexton; Ukwuori G Kalu; Nicola Filippini; Clare E Mackay; Klaus P Ebmeier Journal: Neurobiol Aging Date: 2010-07-08 Impact factor: 4.673
Authors: Edward S Hui; Els Fieremans; Jens H Jensen; Ali Tabesh; Wuwei Feng; Leonardo Bonilha; Maria V Spampinato; Robert Adams; Joseph A Helpern Journal: Stroke Date: 2012-08-28 Impact factor: 7.914
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: P Kochunov; T Coyle; J Lancaster; D A Robin; J Hardies; V Kochunov; G Bartzokis; J Stanley; D Royall; A E Schlosser; M Null; P T Fox Journal: Neuroimage Date: 2009-09-28 Impact factor: 6.556
Authors: Ileana O Jelescu; Magdalena Zurek; Kerryanne V Winters; Jelle Veraart; Anjali Rajaratnam; Nathanael S Kim; James S Babb; Timothy M Shepherd; Dmitry S Novikov; Sungheon G Kim; Els Fieremans Journal: Neuroimage Date: 2016-02-11 Impact factor: 6.556
Authors: Nikki H Stricker; David H Salat; Taylor P Kuhn; Jessica M Foley; Jenessa S Price; Lars T Westlye; Michael S Esterman; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz Journal: Am J Alzheimers Dis Other Demen Date: 2015-04-22 Impact factor: 2.035
Authors: Elan J Grossman; Ivan I Kirov; Oded Gonen; Dmitry S Novikov; Matthew S Davitz; Yvonne W Lui; Robert I Grossman; Matilde Inglese; Els Fieremans Journal: Neuroimage Date: 2015-05-30 Impact factor: 6.556
Authors: Elizabeth M Davenport; Kalyna Apkarian; Christopher T Whitlow; Jillian E Urban; Jens H Jensen; Eliza Szuch; Mark A Espeland; Youngkyoo Jung; Daryl A Rosenbaum; Gerard A Gioia; Alexander K Powers; Joel D Stitzel; Joseph A Maldjian Journal: J Neurotrauma Date: 2016-05-18 Impact factor: 5.269
Authors: Ileana O Jelescu; Jelle Veraart; Vitria Adisetiyo; Sarah S Milla; Dmitry S Novikov; Els Fieremans Journal: Neuroimage Date: 2014-12-09 Impact factor: 6.556